Novo Holdings won European Union antitrust approval for its planned $16.5 billion purchase of Catalent (NYSE:CTLT). The deal is expected to close towards the end of calendar year 2024, subject to ...

Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo Holdings”), a global life ...

SOMERSET, N.J. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide ...

The European Commission has approved unconditionally, under the EU Merger Regulation, the proposed acquisition of Catalent (CTLT) by Novo Holdings. The Commission concluded that the transaction ...

New food hygiene ratings have been awarded to 31 of West Lothian’s establishments, the Food Standards Agency’s website shows.

Novo Holdings, the shareholder that controls Novo Nordisk A/S, won European Union approval for its acquisition of Catalent Inc. The EU unconditionally signed off on the deal after finding that the ...

Catalent is an attractive buyout target for Novo Holdings — which owns 77% of the voting shares in the drugmaker — because it is currently a subcontractor that helps manufacture Wegovy ...

BRUSSELS (Reuters) -Novo Holdings on Friday gained unconditional EU antitrust approval for its $16.5 bln acquisition of U.S. contract drug maker Catalent after EU regulators said they did not see ...

Lying next to Balbardie Park of Peace and enjoying swift access to the Bathgate Hills, this impressive five bedroom home combines comfortable modern living and convenience with a desirable residential ...

Chasing down the leader Bathgate, 3-1 favourite Lahire crashed into the final hurdle in a shuddering accident. The four-year-old inadvertently brought down another FOUR rivals which resulted in ...

The most important investigation before the FTC right now is Novo Holdings’ proposed acquisition of Catalent. Some people might be expecting the FTC to abandon that investigation because of the ...

Update 12:35pm: Adds Reuters report. Catalent (NYSE:CTLT) rose 2.2% amid reports that the European Union's antitrust regulator will likely grant approval for its planned sale to Novo Holdings ...